FDA Approves Two New Quadrivalent Vaccines
The U.S. Food and Drug Administration has approved two new quadrivalent influenza vaccines (IIV4s).
Immunogenicity, Reactogenicity and Safety of Quadrivalent and Trivalent Influenza Vaccines
A total of 4,659 adults aged 18 years or older were randomized to receive a single dose of inactivated quadrivalent influenza vaccine (IIV4) from one of three production lots or an inactivated trivalent influenza vaccine (IIV3) containing either a B/Victoria or B/Yamagata strain.
New Vaccine Developed for Food and Mouth Disease
The first vaccine to protect children against the enterovirus 71, or EV71, that causes hand, foot and mouth disease has been developed by Chineses scientists at Beijing Vigoo Biological.
Man Versus Flu: The Search for a Universal Flu Vaccine
Exploring the growing need of and up-to-date research for a universal flu vaccine.
Choosing Influenza Vaccines
With the advent of new products with new manufacturing processes and added protection, the number of available influenza vaccine presentations has risen to 13. Which ones to choose for your patients can be simplified with a look at the pros and cons of the new compared with the traditional.
Shingles Vaccine May Be Safe for Autoimmune Disease Patients
A recent study conducted at theUniversity of Alabama at Birmingham shows that the shingles vaccine appears to be safe and effective for those suffering from autoimmune diseases.
The Role of Vaccines in Global Disease Prevention
New breakthroughs are giving developing countries the best shot at disease-free living and longevity, but challenges of financing, delivery strategies, efficacy and safety remain.
HIV Vaccine Update
Initial results from a Phase 1 trial of the world’s first HIV vaccine has shown no adverse effects while significantly boosting immunity.
New “FLAB Jab” Reduces Body Weight
Researchers from Braasch Biotech in South Dakota have developed an obesity vaccine that stimulates the immune system to attack a hormone that promotes slow metabolism and weight gain.
The Childhood Vaccine Series: Balancing Health, Safety and Stakeholder Concerns
Following today’s recommended childhood immunization schedule results in improved protection against at least 14 different diseases during the first years of life. As the series continues to evolve, parents and scientists alike are working to ensure the childhood series is safe, while looking for ways to make compliance even easier.